FWP
Firethorn Wealth Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Buy |
10,213
+615
| +6% | +$51K | 0.37% | 61 |
|
|
2025
Q1 | $778K | Buy |
9,598
+751
| +8% | +$60.9K | 0.37% | 57 |
|
|
2024
Q4 | $797K | Buy |
8,847
+769
| +10% | +$69.3K | 0.4% | 54 |
|
|
2024
Q3 | $798K | Buy |
8,078
+329
| +4% | +$32.5K | 0.41% | 53 |
|
|
2024
Q2 | $718K | Buy |
7,749
+1,016
| +15% | +$94.2K | 0.41% | 55 |
|
|
2024
Q1 | $639K | Sell |
6,733
-369
| -5% | -$35K | 0.38% | 58 |
|
|
2023
Q4 | $634K | Buy |
7,102
+1,391
| +24% | +$124K | 0.42% | 50 |
|
|
2023
Q3 | $417K | Buy |
5,711
+829
| +17% | +$60.5K | 0.32% | 66 |
|
|
2023
Q2 | $406K | Buy |
4,882
+318
| +7% | +$26.5K | 0.3% | 64 |
|
|
2023
Q1 | $375K | Buy |
4,564
+337
| +8% | +$27.7K | 0.29% | 66 |
|
|
2022
Q4 | $351K | Buy |
4,227
+612
| +17% | +$50.8K | 0.3% | 76 |
|
|
2022
Q3 | $287K | Buy |
3,615
+135
| +4% | +$10.7K | 0.27% | 85 |
|
|
2022
Q2 | $277K | Buy |
3,480
+446
| +15% | +$35.5K | 0.22% | 93 |
|
|
2022
Q1 | $273K | Buy |
+3,034
| New | +$273K | 0.21% | 98 |
|